Publications by authors named "Michael Millenson"

Claim this Profile
W
Why We Still Kill Patients.
Michael L Millenson

Am J Med Qual· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leape's Making Healthcare Safe: Both Invaluable and Incomplete.
Michael L Millenson

Am J Med Qual· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does a Pandemic Preempt Participatory Medicine?
Michael Louis Millenson

J Particip Med· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
"
"Will you hear my voice?": to engage older patients online, listen to them about their lives offline.
Michael L Millenson

Isr J Health Policy Res· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medicare for All's Political Reality: A Barista Planning to Marry a Movie Star.
Michael L Millenson

J Ambul Care Manage· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-centered care innovations by accountable care organizations: Lessons from leaders.
Michael L Millenson, David B Muhlestein, Emily M O'Donnell, Daniel A Northam Jones, R Sterling Haring

Healthc (Amst)· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient Harms Remain Common.
Michael L Millenson

Health Aff (Millwood)· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NCCN Guidelines Insights: Cancer-Associated Venous Thromboembolic Disease, Version 2.2018.
Michael B Streiff, Bjorn Holmstrom, Dana Angelini, Aneel Ashrani, Paula L Bockenstedt, Michael M Millenson

J Natl Compr Canc Netw· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beyond Dr. Google: the evidence on consumer-facing digital tools for diagnosis.
Michael L Millenson, Jessica L Baldwin, Lorri Zipperer, Hardeep Singh

Diagnosis (Berl)· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Voxtalisib (XL765) in patients with relapsed or refractory non-Hodgkin lymphoma or chronic lymphocytic leukaemia: an open-label, phase 2 trial.
Jennifer R Brown, Mehdi Hamadani, John Hayslip, Ann Janssens, Nina Wagner-Johnston, Michael Millenson

Lancet Haematol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
When "patient centred" is no longer enough: the challenge of collaborative health: an essay by Michael L Millenson.
Michael L Millenson

BMJ· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mobile Health Applications.
Michael L Millenson

Health Aff (Millwood)· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NK cell dysfunction in chronic lymphocytic leukemia is associated with loss of the mature cells expressing inhibitory killer cell Ig-like receptors.
Alexander W MacFarlane, Mowafaq Jillab, Mitchell R Smith, R Katherine Alpaugh, Marion E Cole, Michael M Millenson

Oncoimmunology· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low Level of Blood CD4 T Cells Is an Independent Predictor of Inferior Progression-free Survival in Diffuse Large B-cell Lymphoma.
Julia Judd, Essel Dulaimi, Tianyu Li, Michael M Millenson, Hossein Borghaei

Clin Lymphoma Myeloma Leuk· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-centered care: turning the rhetoric into reality.
Joel S Weissman, Michael L Millenson, R Sterling Haring

Am J Manag Care· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High Body Mass Index in Elderly Patients With DLBCL Treated With Rituximab-Containing Therapy Compensates for Negative Impact of Male Sex.
Zheng Zhou, Alfred W Rademaker, Leo I Gordon, Ann S LaCasce, Allison Crosby-Thompson, Michael M Millenson

J Natl Compr Canc Netw· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What "girls" and "queers" can teach patients.
Michael L Millenson

BMJ· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nivolumab in Patients With Relapsed or Refractory Hematologic Malignancy: Preliminary Results of a Phase Ib Study.
Alexander M Lesokhin, Stephen M Ansell, Philippe Armand, Emma C Scott, Ahmad Halwani, Michael M Millenson

J Clin Oncol· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient- and Family-Centered Care: A Systematic Approach to Better Ethics and Care.
Michael L Millenson, Eve Shapiro, Pamela K Greenhouse, Anthony M DiGioia

AMA J Ethics· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer-Associated Venous Thromboembolic Disease, Version 1.2015.
Michael B Streiff, Bjorn Holmstrom, Aneel Ashrani, Paula L Bockenstedt, Carolyn Chesney, Michael M Millenson

J Natl Compr Canc Netw· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiation for diffuse large B-cell lymphoma in the rituximab era: analysis of the National Comprehensive Cancer Network lymphoma outcomes project.
Bouthaina S Dabaja, Ann M Vanderplas, Allison L Crosby-Thompson, Gregory A Abel, Myron S Czuczman, Michael Millenson

Cancer· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physician incomes in the twenty-first century: time for a new social contract.
Michael L Millenson

J Gen Intern Med· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma.
Stephen M Ansell, Alexander M Lesokhin, Ivan Borrello, Ahmad Halwani, Emma C Scott, Michael M Millenson

N Engl J Med· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frontline bortezomib and rituximab for the treatment of newly diagnosed high tumour burden indolent non-Hodgkin lymphoma: a multicentre phase II study.
Andrew M Evens, Mitchell R Smith, Izidore S Lossos, Irene Helenowski, Michael Millenson

Br J Haematol· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of referring and final pathology for patients with T-cell lymphoma in the National Comprehensive Cancer Network.
Alex F Herrera, Allison Crosby-Thompson, Jonathan W Friedberg, Gregory A Abel, Myron S Czuczman, Michael M Millenson

Cancer· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis